Nektar Therapeutics (LON:0UNL)
London · Delayed Price · Currency is GBP · Price in USD 62.19
+0.91 (1.49%)
At close: Oct 20, 2025
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of 859.11 million as of October 24, 2025. Its market cap has increased by 369.76% in one year.
Market Cap
859.11M
Enterprise Value
859.73M
Revenue
54.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.19
Market Cap Chart
Since May 3, 1994, Nektar Therapeutics's market cap has increased from 42.81M to 859.11M, an increase of 1,906.62%. That is a compound annual growth rate of 9.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 859.11M | 526.97% |
| Dec 31, 2024 | 137.03M | 61.93% |
| Dec 29, 2023 | 84.62M | -76.00% |
| Dec 30, 2022 | 352.54M | -80.85% |
| Dec 31, 2021 | 1.84B | -17.57% |
| Dec 31, 2020 | 2.23B | -22.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |